Amphastar Pharmaceuticals, Inc.

Manufacturer / marketing-authorisation holder

Amphastar Pharmaceuticals, Inc. — 24 products across 2 markets, 3 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

Amphastar Pharmaceuticals, Inc. — 24 productos en 2 mercados, 3 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

Amphastar Pharmaceuticals, Inc. —— 共 24 个产品,覆盖 2 个市场、3 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

24 products · 2 markets · 3 brand names

24 productos · 2 mercados · 3 marcas

24 个产品 · 2 个市场 · 3 个品牌名

Products by country

US (22 records)

Source: api.fda.gov

BrandActive ingredient(s)Form
AMPHADASEHyaluronidaseinjection
Baqsimi高血糖素powder
Baqsimi高血糖素powder
CortrosynCosyntropininjection
—依诺肝素钠injection
—依诺肝素钠injection
—Ganirelixinjection
—依诺肝素钠injection
—Isoproterenolinjection
—醋酸甲羟孕酮injection
—依诺肝素钠injection
—依诺肝素钠injection
—依诺肝素钠injection
—醋酸甲羟孕酮injection
—Vasopressininjection
—Neostigmine Methylsulfateinjection
—Isoproterenolinjection
—特立帕肽injection
—依诺肝素钠injection
—依诺肝素钠injection
—Neostigmine Methylsulfateinjection
—Ingredient not recorded (name-level)kit

CA (2 records)

Source: health-products.canada.ca

BrandActive ingredient(s)Form
Baqsimi高血糖素powder
CortrosynTetracosactidepowder
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.